Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 51.37%46.57M | 44.76%44.28M | 52.71%30.25M | 21.28%112.55M | 34.23%31.39M | 21.04%30.76M | 31.48%30.59M | -4.47%19.81M | -16.96%92.8M | 10.14%23.38M |
| Cost of revenue | 65.41%22.24M | 64.31%20.42M | 36.47%14.44M | -10.85%49.7M | -7.74%13.24M | 6.74%13.45M | -14.88%12.43M | -25.45%10.58M | 8.75%55.74M | 5.00%14.35M |
| Gross profit | 40.47%24.32M | 31.38%23.86M | 71.33%15.81M | 69.61%62.85M | 100.87%18.15M | 35.09%17.32M | 109.59%18.16M | 41.08%9.23M | -38.75%37.06M | 19.43%9.04M |
| Operating expense | 2.85%6.35M | 7.61%7.44M | 4.40%6.67M | -2.75%25.44M | 2.89%7.72M | -5.06%6.17M | 7.28%6.91M | 5.80%6.39M | -3.58%26.16M | -20.06%7.51M |
| Selling and administrative expenses | 2.85%6.35M | 7.61%7.44M | 4.40%6.67M | 2.66%27.2M | 2.89%7.72M | -5.06%6.17M | 7.28%6.91M | 5.80%6.39M | 5.82%26.49M | 2.95%7.51M |
| -Selling and marketing expense | 47.04%472K | 53.06%525K | 17.32%271K | -1.92%1.13M | -22.95%235K | 2.23%321K | 10.65%343K | 3.59%231K | 22.70%1.15M | 33.63%305K |
| -General and administrative expense | 0.43%5.88M | 5.24%6.92M | 3.91%6.4M | 2.87%26.07M | 3.99%7.49M | -5.43%5.85M | 7.11%6.57M | 5.88%6.16M | 5.17%25.34M | 1.96%7.2M |
| Total other operating income | ---- | ---- | ---- | 432.10%1.76M | ---- | ---- | ---- | ---- | --329.9K | ---- |
| Operating profit | 61.29%17.98M | 45.99%16.42M | 221.87%9.14M | 243.30%37.41M | 582.26%10.43M | 76.40%11.15M | 406.62%11.25M | 464.61%2.84M | -67.34%10.9M | 183.71%1.53M |
| Net non-operating interest income (expenses) | 4.26%1.23M | 1.68%1.21M | -8.91%1.12M | 13.68%4.82M | -0.97%1.22M | 6.24%1.18M | 22.75%1.19M | 32.40%1.23M | 103.97%4.24M | 48.21%1.23M |
| Non-operating interest income | 4.26%1.23M | 1.68%1.21M | -8.91%1.12M | 13.68%4.82M | -0.97%1.22M | 6.24%1.18M | 22.75%1.19M | 32.40%1.23M | 103.97%4.24M | 48.21%1.23M |
| Net investment income | -28.37%2.68M | 42.37%3.16M | 331.44%1.14M | -53.44%4.34M | 7.64%662K | 7.54%3.74M | -2.46%2.22M | -59.13%264K | 2.41%9.31M | -83.73%615K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 3.01%445K | -34.72%628K | -24.13%651K | 817.58%3.33M | 3,024.32%1.08M | 241.64%432K | 128.50%962K | 257.72%858K | 85.74%-464.61K | 95.22%-37K |
| Special income (charges) | 88.93%-66.72K | -364.09%-602.64K | ||||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | -88.93%66.72K | ---- | ---- | ---- | ---- | 263.04%602.64K | ---- |
| Other non-operating income (expenses) | 134.73%911K | -311.69%-1.59M | 53.01%3.56M | 15.51%181.19K | 100.81%7K | -2,032.52%-2.62M | -119.00%-385K | 102.96%2.33M | 17.13%156.87K | 24.79%-862K |
| Income before tax | 67.57%23.23M | 30.20%19.83M | 107.56%15.62M | 112.50%50.01M | 441.03%13.4M | 32.43%13.87M | 92.60%15.23M | 180.33%7.52M | -42.99%23.54M | 236.06%2.48M |
| Income tax | 50.20%4.81M | 37.49%3.88M | 89.98%3.22M | 162.38%10.13M | 4,712.00%2.41M | 69.83%3.2M | 150.18%2.82M | 113.07%1.7M | -61.20%3.86M | -85.97%50K |
| Net income | 72.78%18.42M | 28.54%15.95M | 112.68%12.4M | 102.71%39.89M | 353.01%10.99M | 24.21%10.66M | 83.02%12.41M | 208.69%5.83M | -37.22%19.68M | 537.78%2.43M |
| Net income continuous operations | 72.78%18.42M | 28.54%15.95M | 112.68%12.4M | 102.71%39.89M | 353.01%10.99M | 24.21%10.66M | 83.02%12.41M | 208.69%5.83M | -37.22%19.68M | 537.78%2.43M |
| Noncontrolling interests | 165.38%1.86M | 42.67%2.06M | 92.78%1.2M | 110.28%3.35M | 1,350.00%580K | -2.51%699K | 85.15%1.45M | 1,053.70%623K | -55.56%1.59M | 296.63%40K |
| Net income attributable to the company | 66.29%16.57M | 26.67%13.88M | 115.06%11.19M | 102.04%36.54M | 336.30%10.41M | 26.64%9.96M | 82.74%10.96M | 183.81%5.21M | -34.85%18.08M | 495.42%2.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 66.29%16.57M | 26.67%13.88M | 115.06%11.19M | 102.04%36.54M | 336.30%10.41M | 26.64%9.96M | 82.74%10.96M | 183.81%5.21M | -34.85%18.08M | 495.42%2.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 66.31%0.236 | 26.65%0.1977 | 115.25%0.1595 | 102.06%0.5205 | 336.18%0.1483 | 26.58%0.1419 | 82.79%0.1561 | 183.91%0.0741 | -34.85%0.2576 | 496.49%0.034 |
| Diluted earnings per share | 66.31%0.236 | 26.65%0.1977 | 115.25%0.1595 | 102.06%0.5205 | 336.18%0.1483 | 26.58%0.1419 | 82.79%0.1561 | 183.91%0.0741 | -34.85%0.2576 | 496.49%0.034 |
| Dividend per share | 0 | 33.33%0.04 | 0 | 33.33%0.08 | 25.00%0.05 | 0 | 50.00%0.03 | 0 | -25.00%0.06 | 0.00%0.04 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.